Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)

McMaster University239 enrolled

Overview

The purpose of this study is to determine the risk of fetal loss in women with unprovoked venous thromboembolism (VTE) who do not have identifiable inherited thrombophilia compared with women who have the diagnosis of venous thromboembolism (VTE) excluded.

Study Type

OBSERVATIONAL

Enrollment

239

Conditions

Venous Thromboembolism Fetal Death

Interventions

Thrombophilia TestingOTHER

TP testing in Group 1 and 3 only

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Female * At least 18 years of age * Symptomatic for unprovoked venous thromboembolism (deep vein thrombosis \[DVT\] or pulmonary embolism \[PE\]) * At least one pregnancy not terminated intentionally Exclusion Criteria: * Previous VTE in patients with current VTE excluded

Locations (5)

Monash Medical Centre

Clayton, Victoria, Australia

Hamilton General Hospital

Hamilton, Ontario, Canada

McMaster University Medical Centre

Hamilton, Ontario, Canada

St. Joseph's Hospital

Hamilton, Ontario, Canada

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.